[Retracted] Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer

Table 1

Comparison of levels of serum markers among study objects (x ± s).

Group	n	HMGB-1 (ng/ml)	SIL-2R (pmol/L)	TgAb (IU/mL)
Thyroid cancer	50	12.26 ± 1.32^###	108.65 ± 9.75^###	690.65 ± 34.47^###
Benign lesion	50	4.54 ± 0.55^##	45.98 ± 4.70^##	445.98 ± 25.36^##
Control	50	3.98 ± 0.41	41.98 ± 3.15	401.32 ± 15.81

Note. # indicates P < 0.001 versus the benign lesion group; and ## indicates P < 0.001 versus the control group.